Reviva Pharmaceuticals Holdings, Inc. Operating Cash Flow
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Operating Cash Flow of -$5.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.12M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.80M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.80M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.59M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$24.59M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$33.54M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$28.32M.
- Reviva Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$18.96M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$5.92M 10-Q · filed 2026-08-12 | -$11.71M derived: sum of 3 quarters · filed 2026-08-12 | -$17.30M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2026-03-31 | -$3.80M 10-Q · filed 2026-05-13 | -$9.60M derived: sum of 2 quarters · filed 2026-05-13 | -$15.19M derived: sum of 3 quarters · filed 2026-05-13 | -$20.20M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$11.39M derived: sum of 2 quarters · filed 2026-03-30 | -$16.40M derived: sum of 3 quarters · filed 2026-08-12 | -$24.59M 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | -$5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$10.60M derived: sum of 2 quarters · filed 2026-08-12 | -$18.80M 10-Q · filed 2025-11-13 | -$27.90M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-06-30 | -$5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$13.21M 10-Q · filed 2026-08-12 | -$22.31M derived: sum of 3 quarters · filed 2026-08-12 | -$26.55M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-03-31 | -$8.19M 10-Q · filed 2026-05-13 | -$17.29M derived: sum of 2 quarters · filed 2026-05-13 | -$21.54M derived: sum of 3 quarters · filed 2026-05-13 | -$30.01M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | -$9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$13.34M derived: sum of 2 quarters · filed 2026-03-30 | -$21.82M derived: sum of 3 quarters · filed 2026-03-30 | -$33.54M 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | -$4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$12.72M derived: sum of 2 quarters · filed 2025-11-13 | -$24.44M 10-Q · filed 2025-11-13 | -$33.32M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | -$8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$20.20M 10-Q · filed 2025-08-14 | -$29.08M derived: sum of 3 quarters · filed 2025-08-14 | -$35.26M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | -$11.73M 10-Q · filed 2025-05-15 | -$20.60M derived: sum of 2 quarters · filed 2025-05-15 | -$26.78M derived: sum of 3 quarters · filed 2025-05-15 | -$32.10M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | -$8.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | -$15.06M derived: sum of 2 quarters · filed 2025-04-03 | -$20.37M derived: sum of 3 quarters · filed 2025-04-03 | -$28.32M 10-K · filed 2025-04-03 | |||||
| 2023-09-30 | -$6.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$11.50M derived: sum of 2 quarters · filed 2024-11-14 | -$19.45M 10-Q · filed 2024-11-14 | -$24.14M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | -$5.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$13.27M 10-Q · filed 2024-08-14 | -$17.96M derived: sum of 3 quarters · filed 2024-08-14 | -$21.96M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | -$7.95M 10-Q · filed 2024-05-14 | -$12.64M derived: sum of 2 quarters · filed 2024-05-14 | -$16.64M derived: sum of 3 quarters · filed 2024-05-14 | -$20.65M derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | -$4.69M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-15 | -$8.69M derived: sum of 2 quarters · filed 2024-04-15 | -$12.69M derived: sum of 3 quarters · filed 2024-04-15 | -$18.96M 10-K · filed 2024-04-15 | |||||
| 2022-09-30 | -$4.00M derived: 10-K 9 month − 10-Q 6 month · filed 2024-04-15 | -$8.00M derived: sum of 2 quarters · filed 2024-04-15 | -$14.27M 10-K · filed 2024-04-15 | -$18.17M derived: sum of 4 quarters · filed 2024-04-15 | |||||
| 2022-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$10.27M 10-Q · filed 2023-08-14 | -$14.17M derived: sum of 3 quarters · filed 2023-08-14 | -$16.48M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | -$6.27M 10-Q · filed 2023-05-15 | -$10.17M derived: sum of 2 quarters · filed 2023-05-15 | -$12.48M derived: sum of 3 quarters · filed 2023-05-15 | -$13.82M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$6.21M derived: sum of 2 quarters · filed 2023-03-30 | -$7.55M derived: sum of 3 quarters · filed 2023-03-30 | -$10.67M 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.65M derived: sum of 2 quarters · filed 2022-11-14 | -$6.77M 10-Q · filed 2022-11-14 | -$9.70M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$4.46M 10-Q · filed 2022-08-15 | -$7.39M derived: sum of 3 quarters · filed 2022-08-15 | ||||||
| 2021-03-31 | -$3.12M 10-Q · filed 2022-05-16 | -$6.05M derived: sum of 2 quarters · filed 2022-05-16 | |||||||
| 2020-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$4.07M 10-K · filed 2022-03-15 | -$3.73M 10-K · filed 2021-03-22 | ||||||
| 2020-11-30 | -$213.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | -$520.76K 10-Q · filed 2021-01-14 | |||||||
| 2020-09-30 | -$715.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.13M 10-Q · filed 2021-11-15 | |||||||
| 2020-08-31 | -$271.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | -$307.06K 10-Q · filed 2020-10-14 | |||||||
| 2020-06-30 | -$354.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$415.39K 10-Q · filed 2021-08-16 | |||||||
| 2020-05-31 | -$35.46K 10-Q · filed 2020-07-07 | ||||||||
| 2020-03-31 | -$60.66K 10-Q · filed 2021-05-17 | ||||||||
| 2020-02-29 | -$247.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | -$324.78K derived: sum of 2 quarters · filed 2021-01-14 | -$387.23K derived: sum of 3 quarters · filed 2021-01-14 | -$426.59K 10-K · filed 2020-05-04 | |||||
| 2019-12-31 | -$218.44K 10-K/A · filed 2021-05-07 | ||||||||
| 2019-11-30 | -$76.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | -$139.38K derived: sum of 2 quarters · filed 2021-01-14 | -$178.74K 10-Q · filed 2021-01-14 | ||||||
| 2019-08-31 | -$62.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | -$101.81K 10-Q · filed 2020-10-14 | |||||||
| 2019-05-31 | -$39.36K 10-Q · filed 2020-07-07 | ||||||||
| 2019-02-28 | -$220.87K 10-K · filed 2020-05-04 | ||||||||
| 2018-11-30 | -$132.96K 10-Q · filed 2020-01-10 | ||||||||
| 2018-08-31 | -$92.35K 10-Q · filed 2019-10-08 | ||||||||
| 2018-05-31 | $11.66K 10-Q · filed 2019-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |